Inventor · disambiguated record
Kelly Reed Clark
Also filed as: CLARK KELLY R · CLARK KELLY REED
8 granted patents·14 pending applications·201 citations·filing 2003–2022
87Inventor score
Files withULTRAGENYX PHARMACEUTICAL INC5NATIONWIDE CHILDREN S HOSPITAL INC3NATIONWIDE CHILDRENS HOSPITAL3NATIONWIDE CHILDRENS HOSPITAL INC3CLARK KELLY REED2
Top patents by PatentIndex Score
22 records- 0196US9434928B2Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotidesNATIONWIDE CHILDREN'S HOSPITAL INC·Filed 2012·Granted Sep 6, 2016·85 cites·7 claims
- 0294US10105453B2Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotidesNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2016·Granted Oct 23, 2018·12 cites·1 claims
- 0394US8409842B2Recombinant adeno-associated virus productionCLARK KELLY REED·Filed 2009·Granted Apr 2, 2013·63 cites·11 claims
- 0493US7510872B2Recombinant adeno-associated virus productionNATIONWIDE CHILDRENS HOSPITAL·Filed 2004·Granted Mar 31, 2009·39 cites·31 claims
- 0577US7943379B2Production of rAAV in vero cells using particular adenovirus helpersNATIONWIDE CHILDREN S HOSPITAL INC·Filed 2009·Granted May 17, 2011·2 cites·11 claims
- 0674US2022370639A1Recombinant Adeno-Associated Virus Delivery of Alpha-Sarcoglycan PolynucleotidesNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2022·Application pending·0 cites
- 0771US11446396B2Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotidesNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2018·Granted Sep 20, 2022·0 cites·5 claims
- 0867US12492402B2Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3′ untranslated region of the DMPK geneRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2019·Granted Dec 9, 2025·0 cites·12 claims
- 0965US12472268B2Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Nov 18, 2025·0 cites·28 claims
- 1063US2009169513A1Expression of virus entry inhibitors and recombinant AAV thereforNATIONWIDE CHILDRENS HOSPITAL·Filed 2008·Application pending·0 cites
- 1161US2009035327A1Antibody Gene Transfer and Recombinant AAV ThereforNATIONWIDE CHILDRENS HOSPITAL·Filed 2008·Application pending·0 cites
- 1260US2015044170A1Expression of virus entry inhibitors and recombinant aav thereforJOHNSON JR PHILIP R·Filed 2014·Application pending·0 cites
- 1357US2007041943A1Expression of virus entry inhibitors and recombinant AAV thereofCHILDREN S HOSPITAL RES·Filed 2005·Application pending·0 cites
- 1456US2025019721A1Compositions and methods for treating a muscular dystrophyULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1555US2012171160A1Expression of virus entry inhibitors and recombinant aav thereforJOHNSON JR PHILIP R·Filed 2012·Application pending·0 cites
- 1654US2023129893A1Gene therapy for treating propionic acidemiaULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1751US2003219733A1Antibody gene transfer and recombinant AAV thereforFiled 2003·Application pending·0 cites
- 1848US2011201088A1Production of rAAV in Vero Cells Using Particular Adenovirus HelpersNATIONWIDE CHILDREN S HOSPITAL INC·Filed 2011·Application pending·0 cites
- 1948US2022017922A1Methods and compositions for treating glycogen storage diseasesULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 2048US2012027798A1Antibody gene transfer and recombinant aav thereforCLARK KELLY REED·Filed 2011·Application pending·0 cites
- 2139US2020048641A1Methods for enhancing yield of recombinant adeno-associated virusULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2233US2019290710A1Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yieldDIMENSION THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kelly Reed Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →